These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27764892)

  • 41. Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance.
    Gaggini M; Carli F; Rosso C; Buzzigoli E; Marietti M; Della Latta V; Ciociaro D; Abate ML; Gambino R; Cassader M; Bugianesi E; Gastaldelli A
    Hepatology; 2018 Jan; 67(1):145-158. PubMed ID: 28802074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance.
    Bastard JP; Piéroni L; Hainque B
    Diabetes Metab Res Rev; 2000; 16(3):192-201. PubMed ID: 10867719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; De Merulis A; Bezzi M; Osborn JF; Catalano C; Chiesa C
    Hepatology; 2014 Feb; 59(2):461-70. PubMed ID: 23843206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Swimming, but not vitamin E, ameliorates prothrombotic state and hypofibrinolysis in a rat model of nonalcoholic fatty liver disease.
    Sakr HF; Abbas AM; Haidara MA
    J Basic Clin Physiol Pharmacol; 2018 Jan; 29(1):61-71. PubMed ID: 29161233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-alcoholic fatty liver and metabolic syndrome in children: a vicious circle.
    Alterio A; Alisi A; Liccardo D; Nobili V
    Horm Res Paediatr; 2014; 82(5):283-9. PubMed ID: 25324136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histopathology, grading and staging of nonalcoholic fatty liver disease.
    Kleiner DE
    Minerva Gastroenterol Dietol; 2018 Mar; 64(1):28-38. PubMed ID: 28948754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PAI-1 gene 4G/5G polymorphism, cytokine levels and their relations with metabolic parameters in obese children.
    Kinik ST; Ozbek N; Yuce M; Yazici AC; Verdi H; Ataç FB
    Thromb Haemost; 2008 Feb; 99(2):352-6. PubMed ID: 18278185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease.
    Horas H Nababan S; Nishiumi S; Kawano Y; Kobayashi T; Yoshida M; Azuma T
    Arch Biochem Biophys; 2017 Jun; 623-624():64-75. PubMed ID: 28456640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasminogen Activator Inhibitor-1 Levels in Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Alsharoh H; Ismaiel A; Leucuta DC; Popa SL; Dumitrascu DL
    J Gastrointestin Liver Dis; 2022 Jun; 31(2):206-214. PubMed ID: 35574617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are free fatty acids related to plasma plasminogen activator inhibitor 1 in android obesity?
    Bastard JP; Bruckert E; Robert JJ; Ankri A; Grimaldi A; Jardel C; Hainque B
    Int J Obes Relat Metab Disord; 1995 Nov; 19(11):836-8. PubMed ID: 8589788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-alcoholic fatty liver disease fibrosis score and preclinical vascular damage in morbidly obese patients.
    Gentili A; Daviddi G; De Vuono S; Ricci MA; Di Filippo F; Alaeddin A; Mannarino MR; Boni M; Vaudo G; Lupattelli G
    Dig Liver Dis; 2016 Aug; 48(8):904-8. PubMed ID: 27160697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.
    Luukkonen PK; Zhou Y; Sädevirta S; Leivonen M; Arola J; Orešič M; Hyötyläinen T; Yki-Järvinen H
    J Hepatol; 2016 May; 64(5):1167-1175. PubMed ID: 26780287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
    Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG; Mandato C; Poeta M; Vajro P
    World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
    Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
    Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.
    Mansoor S; Yerian L; Kohli R; Xanthakos S; Angulo P; Ling S; Lopez R; Christine CK; Feldstein AE; Alkhouri N
    Dig Dis Sci; 2015 May; 60(5):1440-7. PubMed ID: 25540086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
    Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G
    Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components.
    Privitera G; Spadaro L; Alagona C; Calanna S; Piro S; Rabuazzo AM; Purrello F
    Acta Diabetol; 2016 Jun; 53(3):449-59. PubMed ID: 26496770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathology of non-alcoholic fatty liver disease.
    Bedossa P
    Liver Int; 2017 Jan; 37 Suppl 1():85-89. PubMed ID: 28052629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.